Glucagon-like peptide-1 receptor agonist injectable for twice-daily subcutaneous administration in type 2 diabetes. Biotech and generic firms provide to specialty pharmacies, endocrinology clinics, and hospital pharmacies for procurement in intensive glycemic management by diabetes specialists.